v3.24.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (5,936) $ (7,005)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 922 857
Change in fair value of common warrants classified as a liability (2,103) (3,092)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (276) 573
Deferred offering costs 101 (41)
Accounts payable 125 (184)
Accrued expenses 472 687
Net cash used in operating activities (6,695) (8,205)
Cash flows from investing activities:    
Proceeds from sale of investments 2,032
Net cash provided by investing activities 2,032
Cash flows from financing activities:    
Proceeds from private placement offering, net of offering costs 15,016 5,000
Proceeds from exercise of stock options 69 8
Net cash provided by financing activities 15,085 5,008
Net increase/(decrease) in cash and cash equivalents 8,390 (1,165)
Beginning of period 1,173 4,391
End of period 9,563 3,226
Supplemental disclosure of non-cash financing activities:    
Fair value of common warrant classified as a liability $ 1,188 $ 1,908

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL